FilingsTodayAstera Labs
At a glance
Astera Labs reported 2025 revenue of $852.5M, up 115.1% from $396.3M in 2024. Over 3 years since 2022 ($79.9M), that is growth of about 120.2% a year. Operating margin was 20.3%, up from -75.4% in 2022. 2025 was the highest revenue year in this period. The company posted a loss in 2022, 2023 and 2024.
In the last 12 months 8 insiders reported 0 open-market purchases and 43 sales ($706.9M). 32 of the sales were made under pre-arranged 10b5-1 plans. The largest was a sale of $116.1M by President and COO Sanjay Gajendra on May 26, 2026.
Astera Labs filed 8 current reports (Form 8-K) in the last 12 months, most often for results of operations (4), officer or director change (2), shareholder vote results (1) and material agreement (1). The latest officer or director change was reported on Feb 10, 2026. It reported a material agreement or a completed acquisition or disposal 1 time.
3 of the 20 investors tracked here held Astera Labs at the last quarter end, worth $175.7M combined. It is the largest weight for Renaissance Technologies (0.1% of its portfolio), followed by National Pension Service (Korea) (0.1%). Added: Renaissance Technologies. Reduced: National Pension Service (Korea) and Bridgewater Associates.
Annual results
| Year | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Net income | -$58.3M | -$26.3M | -$83.4M | $219.1M |
| Diluted EPS | $-1.71 | $-0.71 | $-0.64 | $1.22 |
Fiscal year ends Dec 31 · incorporated in DE
Tracked investors holding (13F)
Weight is the share of each investor's portfolio, as of the quarter end.
Current reports (8-K, last 12 months)
Insider open-market trades (last 12 months)
Source: SEC EDGAR. How figures are combined